The inflammatory role of the platelet in aspirin-exacerbated respiratory disease.
血小板在阿司匹林加剧的呼吸道疾病中的炎症作用。
基本信息
- 批准号:8528709
- 负责人:
- 金额:$ 13.72万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-08-15 至 2017-07-31
- 项目状态:已结题
- 来源:
- 关键词:AdherenceAdhesionsAdultAffectAgonistAreaAspirinAsthmaAwardBiochemicalBiological AssayBiologyBiometryBloodBlood PlateletsBronchoconstrictionBronchoconstrictor AgentsCharacteristicsChronicClinicalClinical ResearchCommitComplementDataDefectDevelopment PlansDiagnosisDinoprostoneDiseaseDoseEP4 receptorEicosanoidsEnvironmentEosinophiliaFive-Year PlansFrequenciesFundingGenerationsGoalsHomeostasisHypersensitivityImmunologyIn VitroIndividualInflammationInflammatoryIngestionInvestigationIsraelKnowledgeLaboratoriesLeadLeukocyte Adhesion MoleculesLeukocyte-Adhesion ReceptorsLeukocytesLeukotriene A4Leukotriene C4Leukotriene E4LeukotrienesLifeLinkLungLung diseasesMeasuresMedicineMentorsMentorshipMolecularNasal PolypsNoseP-SelectinPathogenesisPatientsPharmaceutical PreparationsPhenotypePhysiciansPlant RootsPlatelet ActivationPopulationPositioning AttributeProductionProstaglandinsProteinsReactionReceptor SignalingRecurrenceRelative (related person)Research DesignResearch PersonnelResourcesRoleScientistSecureSeveritiesSignal TransductionSignaling ProteinSinusSinusitisSourceSyndromeTestingThromboxane A2TimeTissuesTriad Acrylic ResinUnited StatesUnited States National Institutes of HealthUp-RegulationUrineWorkWritingbasecareercareer developmentcyclooxygenase 1cyclooxygenase 2cysteinyl-leukotrienedidactic educationeosinophilexperiencegranulocytehuman WFDC2 proteinin vivoinhibitor/antagonistinsightleukocyte activationleukotriene-C4 synthasemigrationmonocyteneglectneutrophilnovelperipheral bloodpolyposispreventprostaglandin EP2 receptorpublic health relevancereceptorresearch and developmentrespiratoryresponseskillsurinary
项目摘要
DESCRIPTION (provided by applicant): This proposal details a five-year plan to provide the candidate, Tanya Laidlaw, MD, with the knowledge and expertise to become an independent investigator in the field of Allergy and Immunology. The studies focus on a previously unrecognized role for platelets as effectors of aspirin-exacerbated respiratory disease (AERD). AERD is characterized by asthma, recurrent nasal polyps, and respiratory reactions that occur upon ingestion of aspirin or other inhibitors of cyclooxygenase-1. Although the cause is unknown, the syndrome is consistently associated with tissue eosinophilia and elevated generation of cysteinyl leukotrienes, the latter of which may reflect a disturbance in the production of prostaglandin E2 or the function of its receptors (EP receptors). The candidate has discovered that platelets from individuals with AERD demonstrate decreased function of two prostaglandin E2 receptors, EP2 and EP4, which lowers the threshold for activation of their platelets and allows for increased platelet adhesion onto inflammatory granulocytes and monocytes. As a result, the blood of individuals with AERD contains substantially more platelet-leukocyte aggregates than does the blood of aspirin tolerant controls. Using a combination of cellular, biochemical, and molecular approaches, the candidate will test the hypothesis that abnormal EP2 and EP4 signaling on platelets unifies the phenomena of leukotriene overproduction, tissue eosinophilia, and aspirin-induced reactions in patients with AERD. The results from these studies will advance our understanding of the pathogenesis of AERD. During the period of support the candidate will complement her laboratory skills with didactic coursework to develop skills in clinical study design, advanced biostatistics, and scientific writing. This will then facilitate her transition to independence during the third and fourth yearsof the award. Dr. Laidlaw will work under the mentorship of Joshua Boyce, MD, an expert in eicosanoid biology and mechanisms of inflammation, who has an excellent record of mentoring young investigators for successful careers in academic medicine. Dr. Laidlaw has also assembled a team of extraordinary physician scientists, including Drs. Elliot Israel, Mariana Castells, and K. Frank Austen, who have committed their time, resources, and expertise to facilitate her career development and research goals. Under their mentorship and guidance, in an ideal scientific and clinical environment at the BWH, the translational work, didactic curriculum, and career development plan will position the candidate to secure independent NIH funding and to establish herself as a physician scientist with a focus on AERD, a relatively neglected area of investigation.
描述(由申请人提供):本提案详细说明了一项五年计划,旨在为候选人Tanya Laidlaw医学博士提供成为过敏和免疫学领域的独立研究员的知识和专业知识。这些研究的重点是血小板作为阿司匹林加重的呼吸系统疾病(AERD)的效应者之前未被认识到的作用。AERD的特征是哮喘、复发性鼻息肉和因摄入阿司匹林或其他环氧合酶-1抑制剂而发生的呼吸反应。虽然病因不明,但该综合征始终与组织嗜酸性粒细胞增多和半胱氨酰白三烯的生成增加有关,后者可能反映前列腺素E2的产生或其受体(EP受体)的功能障碍。这位候选人发现,AERD患者的血小板显示出两种前列腺素E2受体EP2和EP4的功能下降,这降低了他们血小板激活的门槛,并允许血小板与炎性粒细胞和单核细胞粘附性增加。结果,与阿司匹林耐受对照组相比,AERD患者的血液中含有更多的血小板-白细胞聚集物。使用细胞、生化和分子方法的组合,候选人将检验这一假设,即血小板上异常的EP2和EP4信号统一了AERD患者的白三烯过度生产、组织嗜酸性粒细胞增多和阿司匹林诱导的反应的现象。这些研究结果将促进我们对AERD发病机制的理解。在支持期间,候选人将通过教学课程补充她的实验室技能,以发展临床研究设计、高级生物统计学和科学写作方面的技能。这将有助于她在获奖的第三年和第四年过渡到独立。莱德洛博士将在医学博士约书亚·博伊斯的指导下工作,博伊斯是二十烷类生物和炎症机制方面的专家,他在指导年轻研究人员在学术医学领域取得成功方面有着出色的记录。莱德洛博士还组建了一支杰出的内科科学家团队,其中包括埃利奥特·伊斯雷尔博士、玛丽安娜·卡斯特尔斯博士和K·弗兰克·奥斯汀博士,他们投入了时间、资源和专业知识来促进她的职业发展和研究目标。在他们的指导和指导下,在BWH理想的科学和临床环境中,翻译工作、教学课程和职业发展计划将使候选人能够获得独立的NIH资金,并确立自己作为内科科学家的地位,专注于AERD,这是一个相对被忽视的研究领域。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Tanya Maria Laidlaw其他文献
Tanya Maria Laidlaw的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Tanya Maria Laidlaw', 18)}}的其他基金
Prostaglandin D2: A Key Mediator of Aspirin-Exacerbated Respiratory Disease
前列腺素 D2:阿司匹林加重呼吸系统疾病的关键介质
- 批准号:
9332401 - 财政年份:2015
- 资助金额:
$ 13.72万 - 项目类别:
The inflammatory role of the platelet in aspirin-exacerbated respiratory disease.
血小板在阿司匹林加剧的呼吸道疾病中的炎症作用。
- 批准号:
8703167 - 财政年份:2012
- 资助金额:
$ 13.72万 - 项目类别:
The inflammatory role of the platelet in aspirin-exacerbated respiratory disease.
血小板在阿司匹林加剧的呼吸道疾病中的炎症作用。
- 批准号:
8374246 - 财政年份:2012
- 资助金额:
$ 13.72万 - 项目类别:
Project 3. Mechanisms of benefit of biologic agents for patients with aspirin-exacerbated respiratory disease (AERD)
项目3.生物制剂对阿司匹林急性呼吸道疾病(AERD)患者的获益机制
- 批准号:
10626855 - 财政年份:2011
- 资助金额:
$ 13.72万 - 项目类别:
Project 3. Mechanisms of benefit of biologic agents for patients with aspirin-exacerbated respiratory disease (AERD)
项目3.生物制剂对阿司匹林急性呼吸道疾病(AERD)患者的获益机制
- 批准号:
10260785 - 财政年份:2011
- 资助金额:
$ 13.72万 - 项目类别:
Project 3. Mechanisms of benefit of biologic agents for patients with aspirin-exacerbated respiratory disease (AERD)
项目3.生物制剂对阿司匹林急性呼吸道疾病(AERD)患者的获益机制
- 批准号:
10456246 - 财政年份:2011
- 资助金额:
$ 13.72万 - 项目类别:
相似海外基金
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y004841/1 - 财政年份:2024
- 资助金额:
$ 13.72万 - 项目类别:
Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
- 批准号:
BB/Y001427/1 - 财政年份:2024
- 资助金额:
$ 13.72万 - 项目类别:
Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y005414/1 - 财政年份:2024
- 资助金额:
$ 13.72万 - 项目类别:
Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
- 批准号:
10669829 - 财政年份:2023
- 资助金额:
$ 13.72万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10587090 - 财政年份:2023
- 资助金额:
$ 13.72万 - 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
- 批准号:
10821599 - 财政年份:2023
- 资助金额:
$ 13.72万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10841832 - 财政年份:2023
- 资助金额:
$ 13.72万 - 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
- 批准号:
10532480 - 财政年份:2022
- 资助金额:
$ 13.72万 - 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
- 批准号:
10741261 - 财政年份:2022
- 资助金额:
$ 13.72万 - 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
- 批准号:
10674894 - 财政年份:2022
- 资助金额:
$ 13.72万 - 项目类别:














{{item.name}}会员




